Table 3.

Summary of clinical characteristics and serum mesothelin levels in six patients with peritoneal mesothelioma who underwent surgical debulking and continuous hyperthermic peritoneal perfusion with cisplatin

PatientGenderAgePathologyMesothelin expressionAscitesDebulked (%)Mesothelin levels (ng/mL)
BaselinePOD 1POD 7
AM68EpithelialYesYes9522.25.5<1
BM63EpithelialYesYes7024<1<1
CF52EpithelialYesNo8011.311.2<1
DF31EpithelialYesYes1041.634.426
EM46BiphasicNoNo90<1<1<1
FM51EpithelialYesNo100<1<1<1
  • Abbreviation: POD, postoperative day.